Skip to main content
. Author manuscript; available in PMC: 2013 Feb 15.
Published in final edited form as: Radiat Res. 2012 Jun 27;178(1):7–16. doi: 10.1667/rr3085.1

FIG. 2.

FIG. 2

The significance of the shape of the dose-response curve for radiation-induced cancer at high doses. Panel A: Cancer risks decrease at high doses, due to cell killing – the Gray model: In this scenario high normal tissue doses will not contribute significantly to secondary cancer risks. Panel B: Cancer risks do not decrease sharply at high doses: In this scenario high normal-tissue doses may dominate secondary cancer risks.